HIGH PURITY ORITAVANCIN AND METHOD OF PRODUCING SAME

Drug substance preparations of oritavancin having high purity are disclosed, along with pharmaceutical compositions comprising such oritavancin drug substance preparations, and drug products or dosage forms comprising such pharmaceutical compositions. L'invention concerne des préparations de su...

Full description

Saved in:
Bibliographic Details
Main Authors RAFAI FAR, ADEL, PETZEL, JAMES P, REAMER, DOUGLAS M, KRISHNA, GOPAL, PRUYNE, JULIE J, DING, MIN, BURKAR, SANJAY R, KNABLE, CARL M
Format Patent
LanguageEnglish
French
Published 14.02.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Drug substance preparations of oritavancin having high purity are disclosed, along with pharmaceutical compositions comprising such oritavancin drug substance preparations, and drug products or dosage forms comprising such pharmaceutical compositions. L'invention concerne des préparations de substances médicamenteuses d'oritavancine ayant une pureté élevée, ainsi que des compositions pharmaceutiques comprenant de telles préparations de substances médicamenteuses d'oritavancine, ainsi que des produits médicamenteux ou des formes galéniques comprenant lesdites compositions pharmaceutiques.
AbstractList Drug substance preparations of oritavancin having high purity are disclosed, along with pharmaceutical compositions comprising such oritavancin drug substance preparations, and drug products or dosage forms comprising such pharmaceutical compositions. L'invention concerne des préparations de substances médicamenteuses d'oritavancine ayant une pureté élevée, ainsi que des compositions pharmaceutiques comprenant de telles préparations de substances médicamenteuses d'oritavancine, ainsi que des produits médicamenteux ou des formes galéniques comprenant lesdites compositions pharmaceutiques.
Author RAFAI FAR, ADEL
PETZEL, JAMES P
REAMER, DOUGLAS M
KNABLE, CARL M
PRUYNE, JULIE J
BURKAR, SANJAY R
KRISHNA, GOPAL
DING, MIN
Author_xml – fullname: RAFAI FAR, ADEL
– fullname: PETZEL, JAMES P
– fullname: REAMER, DOUGLAS M
– fullname: KRISHNA, GOPAL
– fullname: PRUYNE, JULIE J
– fullname: DING, MIN
– fullname: BURKAR, SANJAY R
– fullname: KNABLE, CARL M
BookMark eNrjYmDJy89L5WQw8fB091AICA3yDIlU8AeSjmGOfs6efgqOfi4Kvq4hHv4uCv5uCgFB_i6hQGF3hWBHX1ceBta0xJziVF4ozc0g7-Ya4uyhm1qQH59aXJCYnJqXWhLv7GhkaWpqZGrmbExYBQAcoygo
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate ORITAVANCINE A HAUTE PURETE ET SON PROCEDE DE PRODUCTION
ExternalDocumentID CA2955256C
GroupedDBID EVB
ID FETCH-epo_espacenet_CA2955256C3
IEDL.DBID EVB
IngestDate Fri Jul 19 12:46:16 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CA2955256C3
Notes Application Number: CA20152955256
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230214&DB=EPODOC&CC=CA&NR=2955256C
ParticipantIDs epo_espacenet_CA2955256C
PublicationCentury 2000
PublicationDate 20230214
PublicationDateYYYYMMDD 2023-02-14
PublicationDate_xml – month: 02
  year: 2023
  text: 20230214
  day: 14
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies ABBVIE INC
THE MEDICINES COMPANY
RelatedCompanies_xml – name: ABBVIE INC
– name: THE MEDICINES COMPANY
Score 3.4404013
Snippet Drug substance preparations of oritavancin having high purity are disclosed, along with pharmaceutical compositions comprising such oritavancin drug substance...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title HIGH PURITY ORITAVANCIN AND METHOD OF PRODUCING SAME
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230214&DB=EPODOC&locale=&CC=CA&NR=2955256C
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT8MwDLbGQMANBmi8c0C9VWxt0m6HCnVJuw6pD5V2GqeJtkFwGRMr4u_jVBtw2SWKHMlJLDmfndgOwJ3JXnsmK5leSGOoU9t-UcnKhW5WfbTXqTTMJuQ_jKwgp48zNmvB2yYXpqkT-t0UR0SNKlHf6-a8Xv5dYokmtnJ1X7wj6ePBzxyhrb1jtKeNPtXEyPGSWMRc49zhrhaljjFkDNGd78CuMqJVlX1vOlI5Kcv_gOIfwV6CvBb1MbTkogMHfPPvWgf2w_VzN3bXmrc6ARpMxgFJ8nSSPZMYW3eqQuwi4kaChF4WxILEPknSWORIHpMnN_RO4db3Mh7oOP38d6dz7m7WaZ5BG_1_2QVC5dBCs4ZJhlBsVfaglAPUy4FV9qrCLItz6G7jcrF96BIOlbxUAHKfXkG7_vyS14ivdXHTiOYHbxN5Nw
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dT8IwEL8gGvFNUYOf9MHsbRG2doOHxYx2Yyj7CA6CT4SNGn1BIjP--14XUF94aZprcm0vuf7u2rsrwJ3JXlsmy5meSaOrU9ueq2TlTDcXbbTXqTTMMuQ_jKxgTB-nbFqBt20uTFkn9LssjogalaO-F-V5vfq7xBJlbOX6PntH0seDnzpC23jHaE8bbaqJnuMlsYi5xrnDXS0aOUaXMUR3vgf7tqrNqwynSU_lpKz-A4p_DAcJ8loWJ1CRyzrU-PbftTochpvnbuxuNG99CjQY9AOSjEeD9IXE2LoTFWIXETcSJPTSIBYk9kkyisUYyX3y7IbeGTR9L-WBjtPPfnc64-52neY5VNH_lw0gVHYtNGuYZAjF1sLu5LKDetmx8tYiM_PsAhq7uFzuHmpCLUjD4Ww4iJ6u4EjJTgUjt-k1VIvPL3mDWFtkt6WYfgBCf3wk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=HIGH+PURITY+ORITAVANCIN+AND+METHOD+OF+PRODUCING+SAME&rft.inventor=RAFAI+FAR%2C+ADEL&rft.inventor=PETZEL%2C+JAMES+P&rft.inventor=REAMER%2C+DOUGLAS+M&rft.inventor=KRISHNA%2C+GOPAL&rft.inventor=PRUYNE%2C+JULIE+J&rft.inventor=DING%2C+MIN&rft.inventor=BURKAR%2C+SANJAY+R&rft.inventor=KNABLE%2C+CARL+M&rft.date=2023-02-14&rft.externalDBID=C&rft.externalDocID=CA2955256C